关于我国生物医学科学中长期战略发展和生物医学战略平台建设的建议  

PROPOSAL CONCERNING THE MID & LONG TERM STRATEGIC DEVELOPMENT FOR THE NATIONAL BIOMEDICAL SCIENCE AND CONSTRUCTION OF THE BIOMEDICAL STRATEGIC PLATFORM

作　　者：徐恒 何维[2] 刘谦[2] 

机构地区：[1]美国Emory大学医学院,atlanta30322 [2]中国医学科学院中国协和医科大学,北京100730

出　　处：《中国科学基金》2004年第4期218-221,共4页Bulletin of National Natural Science Foundation of China

摘　　要：根据我国生物医学科学发展的现状和问题,文中提议在制订国家中长期科学和技术发展规划时应考虑国外当前生物医学科学战略转移所带来的挑战和机遇;建议以系统分子生物学和多系统生物学为基础,把“DNA复制调控和人类疾病”的研究作为我国生物医学科学中长期战略发展的一个切入点和突破点。以此搭建我国生物医学科学的战略平台,建设系统的国家生物医学学科和完整的生物医学科学研发体系,并充分发挥基金激励机制。Considering the present situations and problems existing in the development of biomedical science in our country, we propose to take opportunities of the strategy change in the biomedical science in the world today when the government sets out the national mid & long-term program for the development of science and technology; also propose to make the study of 'DNA replication and human diseases' as a starting point in the mid & long term strategic development for the national biomedical science, while taking the study on System Molecule Biology and Systems Biology as a basis. This can be used to set up a strategic platform for the national biomedical science development, and to build up a complete biomedical research and development system managed by the fund rewarding mechanism that is directed by the platform of national biomedicine disciplines and regulations.

关 键 词：生物医学 系统分子生物学 多系统生物学 DNA复制调控 人类疾病 

分 类 号：R318[医药卫生—生物医学工程]